Position in ABCL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$403,793
+$132,587 QoQ
Shares Held
115,700
+45.9% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 138 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Handelsbanken Fonder AB holds $535,000,150 across 75 Biotechnology names. ABCL ranks #70 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
220,847 | $98,617,019 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125,036 | $96,607,815 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,462 | $45,151,181 | |
| 4 | ARGX |
Argenx SE
|
54,926 | $40,109,711 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
493,469 | $31,892,901 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
91,400 | $23,610,448 | |
| 7 | RPRX |
Royalty Pharma plc
|
435,267 | $20,879,757 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
194,000 | $17,921,720 |
All Filings in ABCL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $403,793 | 115,700 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $271,206 | 79,300 | Shares | Sole | 2026-02-06 | |
| 2024-09-30 | $181,740 | 69,900 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $206,904 | 69,900 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $272,706 | 60,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $259,234 | 45,400 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $184,000 | 40,000 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $258,400 | 40,000 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||